Advanced learning toward faster, more accurate diagnosis of disease.
Decision support & prognostic tests for high-volume specimens will mean major improvements in speed and a significant reduction in errors.
We help researchers identify patients that benefit from novel therapies and make scalable personalized medicine a reality with AI-powered pathology.
PathAI is paving the way for access to advanced diagnostic services at a sustainable cost for the regions and people that need them the most.
In the Press
- BBJ releases the 2020 Best Places to Work
- June 16, 2020
- 30 Boston Healthtech Startups and Companies You Need to Know
- February 16, 2020
- PathAI reports algorithm on par in PD-L1 immunotherapy studies
- November 7, 2019
- Merck, BMS chip in to PathAI's series B, bringing total to $75M
- November 6, 2019